These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25551752)

  • 1. Identifying glioblastoma gene networks based on hypergeometric test analysis.
    Stathias V; Pastori C; Griffin TZ; Komotar R; Clarke J; Zhang M; Ayad NG
    PLoS One; 2014; 9(12):e115842. PubMed ID: 25551752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
    Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
    Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
    Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
    Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
    Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
    Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.
    Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S
    J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    Han J; Puri RK
    J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
    Vasaikar S; Tsipras G; Landázuri N; Costa H; Wilhelmi V; Scicluna P; Cui HL; Mohammad AA; Davoudi B; Shang M; Ananthaseshan S; Strååt K; Stragliotto G; Rahbar A; Wong KT; Tegner J; Yaiw KC; Söderberg-Naucler C
    BMC Cancer; 2018 Feb; 18(1):154. PubMed ID: 29409474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray.
    Wang L; Wei B; Hu G; Wang L; Bi M; Sun Z; Jin Y
    Mol Med Rep; 2015 Aug; 12(2):1991-6. PubMed ID: 25901754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug and disease signature integration identifies synergistic combinations in glioblastoma.
    Stathias V; Jermakowicz AM; Maloof ME; Forlin M; Walters W; Suter RK; Durante MA; Williams SL; Harbour JW; Volmar CH; Lyons NJ; Wahlestedt C; Graham RM; Ivan ME; Komotar RJ; Sarkaria JN; Subramanian A; Golub TR; Schürer SC; Ayad NG
    Nat Commun; 2018 Dec; 9(1):5315. PubMed ID: 30552330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Thermodynamic-Based Interpretation of Protein Expression Heterogeneity in Different Glioblastoma Multiforme Tumors Identifies Tumor-Specific Unbalanced Processes.
    Kravchenko-Balasha N; Johnson H; White FM; Heath JR; Levine RD
    J Phys Chem B; 2016 Jul; 120(26):5990-7. PubMed ID: 27035264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
    Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
    Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide expression profiling of glioblastoma using a large combined cohort.
    Tang J; He D; Yang P; He J; Zhang Y
    Sci Rep; 2018 Oct; 8(1):15104. PubMed ID: 30305647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
    Chai Y; Wang C; Liu W; Fan Y; Zhang Y
    J Neurooncol; 2019 Sep; 144(2):293-301. PubMed ID: 31236818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.